Armata Pharmaceuticals (ARMP) Interest Coverage Ratio (2013 - 2026)
Armata Pharmaceuticals' (ARMP) quarterly Interest Coverage Ratio came in at 1.58 in Q1 2026, up 30.51% year-on-year from 1.21 in Q1 2025, and up 44.74% quarter-over-quarter from 2.86 in Q4 2025.
Armata Pharmaceuticals (ARMP) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has disclosed Interest Coverage Ratio across 13 years of filings, most recently posting 1.58 for Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 1.58, up 30.51% year-over-year; the trailing twelve-month figure through Mar 2026 was 2.01 (up 37.78% YoY), and the FY2025 annual result was 2.21, up 44.1% from the prior year.
- Interest Coverage Ratio came in at 1.58 for Q1 2026 at Armata Pharmaceuticals, up from 2.86 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1.58 in Q1 2026 to a low of 8.79 in Q3 2023.
- The 4-year median for Interest Coverage Ratio is 3.21 (2024), against an average of 3.84.
- Across the five-year window, Interest Coverage Ratio jumped 62.02% in 2024 and rose 11.0% in 2025, its largest moves.
- Armata Pharmaceuticals' Interest Coverage Ratio stood at 6.61 in 2023, then jumped by 51.36% to 3.21 in 2024, then grew by 11.0% to 2.86 in 2025, then jumped by 44.74% to 1.58 in 2026.
- The last three Interest Coverage Ratio figures came in at 1.58 (Q1 2026), 2.86 (Q4 2025), and 1.79 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -258.33 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 11.79 |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - | -1.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.58 |
| Dec 31, 2025 | -2.86 |
| Sep 30, 2025 | -1.79 |
| Jun 30, 2025 | -1.80 |
| Mar 31, 2025 | -2.27 |
| Dec 31, 2024 | -3.21 |
| Sep 30, 2024 | -3.34 |
| Jun 30, 2024 | -4.38 |
| Mar 31, 2024 | -5.62 |
| Dec 31, 2023 | -6.61 |
| Sep 30, 2023 | -8.79 |
| Sep 30, 2021 | -3,071.50 |
| Mar 31, 2021 | -87.66 |
| Dec 31, 2020 | -64.53 |
| Sep 30, 2020 | -37.49 |
| Jun 30, 2020 | -32.32 |
| Mar 31, 2020 | -30.95 |
| Dec 31, 2019 | -21.35 |
| Sep 30, 2019 | -35.67 |
| Jun 30, 2019 | -22.43 |